US5983893A - Inhalation device - Google Patents

Inhalation device Download PDF

Info

Publication number
US5983893A
US5983893A US08/663,266 US66326696A US5983893A US 5983893 A US5983893 A US 5983893A US 66326696 A US66326696 A US 66326696A US 5983893 A US5983893 A US 5983893A
Authority
US
United States
Prior art keywords
inhaler
inhalation device
dispersing chamber
air
inhalation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US08/663,266
Other languages
English (en)
Inventor
Kjell Wetterlin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
Astra AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra AB filed Critical Astra AB
Assigned to ASTRA AKTIEBOLAG reassignment ASTRA AKTIEBOLAG ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: WETTERLIN KJELL
Application granted granted Critical
Publication of US5983893A publication Critical patent/US5983893A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0086—Inhalation chambers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0086—Inhalation chambers
    • A61M15/0088—Inhalation chambers with variable volume
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • A61M15/0065—Inhalators with dosage or measuring devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder

Definitions

  • the present invention relates to an inhalation device for inhalation of a pharmaceutically active substance from a reservoir in an inhaler comprising an inhalation channel with an air inlet and an air outlet, said device comprising a dispersing chamber having an air inlet and an air outlet into which the active substance may be sucked from said reservoir through the air outlet and means for allowing a user to inhale the active substance from said dispersing chamber, said dispersing chamber being defined by at least a first non-movable element and a second movable element, said second element being substantially cylinder-formed, said first element being arranged in said second element whereby a vacuum or negative pressure is created in said dispersing chamber when said first and second elements are moved in relation to each other.
  • the inhalation device is preferably a breath-actuated dry-powder inhaler, containing multiple doses of a medicament containing an active substance, the inhaler having maneuvering unit for loading one dose of the medicament to a dosing unit and providing said dose in a position for inhalation.
  • An inhaler of the prescribed type is described in EP-A-0 069 715 and EP-A-0 237 507.
  • the device according to the invention is especially designed for patients who are not able to actively inhale or who are not able to create the inhalation flow necessary to release and lift the dose of the substance into the inhalation channel and to the lungs when using a breath-actuated inhaler.
  • Inhalable pharmaceutically active substances are generally used for treatment of diseases in the bronchial and pulmonary area, such as asthma and chronic bronchitis.
  • Various embodiments of inhalation devices or apparatus are used for the purpose. The function of these known devices depends on the creation of an airflow through the inhalation device caused by an inhalation by the patient. The airflow causes active substance to moved from a release position into the airflow in which it is dispersed.
  • a specially advantageous inhaler of the above mentioned type is the dry-powder, breath-actuated multidose inhaler TURBUHALER®, schematically described in the above mentioned EP-patents.
  • Some patients such as small children and elderly people with diseases in the bronchial area are not able to use a breath-actuated inhaler as it might be hard or even impossible for these patients to achieve the necessary inhalation flow and these patients are today reduced to the use of inhalers using pressurized gas, i.e. freon.
  • Such inhalers suffer from many known disadvantages, such as unwanted side effects.
  • PMDIs pressurized metered dose inhalers
  • expansion chambers into which the substance, with the pressurized gas, is dispersed.
  • spacers and a typical spacer is known from GB 1 565 029.
  • inhalation devices including dispersion chambers have been developed for breath-actuated dry-powder inhalers of the above mentioned type.
  • Such an inhalation device is described in EP-A-0 548 152.
  • This device is however bulky and contains several mechanical parts which makes the device complicated and expensive to produce and to use. The reliability is not very high due to the complexibility of the device.
  • the present invention relates to an inhalation device of the above mentioned type which can be used by patients having reduced ability to create an inhalation flow necessary to lift the dose from the release position into the inhalation channel when using a breath-actuated inhaler, and which can be used to administer Inhalable substances to a patient being anesthetized.
  • the invention provides a device which facilitates the use of especially a TURBUHALER® for patients presently being reduced to the use of pressurized metered-dose inhalers.
  • the inhalation device according to the invention has a non-complicated construction with few mechanical parts, is simple and cheap to produce and is easy to use by the patient.
  • a first non-movable element is fixed on the inhaler so that a second element will move in relation to both the first element and the inhaler when the device is activated for inhalation.
  • the present invention also includes a method of dispersing a pharmaceutically active substance, in a dispersing chamber by creating a negative pressure or vacuum in said dispersing chamber by using a device according to the invention.
  • the dispersed substance could thereby be inhaled using an ordinary inhalation flow or it could be pressed out from the inhalation device.
  • FIG. 1 shows a schematic view of a section of the inhalation device according to a first embodiment of the invention
  • FIG. 2 shows a schematic view of a section of the second embodiment of the inhalation device according to the invention.
  • the device according to the invention is intended to be used in connection with an inhaler for inhalation of a pharmaceutically active substance, e.g. the breath-actuated, dry-powder, multidose inhaler 12 sold under the trademark TURBUHALER® .
  • a pharmaceutically active substance e.g. the breath-actuated, dry-powder, multidose inhaler 12 sold under the trademark TURBUHALER® .
  • the inhalation device according to the invention may be modified within the scope of the appended claims to be used with any dry-powder inhaler which when activated positions a dose of the medicament in a release position in the inhalation channel.
  • the preferred inhaler 12 is provided with a reservoir for storing the substance, a metering or dosing unit, and an inhalation channel having an air inlet and an air outlet.
  • the inhaler is also provided with operating means comprising a maneuvering unit 13 for moving a metering device from a loading position in which a predetermined dose of the substance to be inhaled is metered into the metering device and a release position where the dose is placed in the inhalation channel, released and carried by the inhalation air through the channel to the air outlet or mouthpiece 15 of the inhaler.
  • the inhalation device comprises a first substantially non-moving element 10 which is provided on the air outlet or mouth piece 15 of the inhaler.
  • the first element 10 is formed as a piston having an opening 26 which, when the piston is arranged on the air outlet of the inhaler, coincides with the opening 11 of the air outlet.
  • the connection between the air outlet or mouth piece 15 of the inhaler and the piston is air tight through a sealing or as in the preferred embodiment the piston is rigidly mounted on the outer walls of the air outlet or mouth piece 15 of the inhaler in order to prevent air from entering between the two parts.
  • the piston could be glued, welded or rigidly fastened in any other manner to the inhaler.
  • a movable second element 6 is provided around said first substantially non-moving element, i.e. the piston 10.
  • Said second element 6 is hollow and substantially formed as a cylinder.
  • the walls merge and define a cone-shaped part 28.
  • a further cylinder 22 having a smaller diameter than the cylinder 6 defining the second element is arranged.
  • Said cylinder 22 defines the air outlet of the dispersing chamber 20 and the inhalation device and is formed as a mouth piece or nose adapter part.
  • the piston 10 is arranged inside the cylinder 6.
  • the piston thereby defines the bottom of the second element 6.
  • a dispersing chamber 20 is defined in the cylinder 6 above the piston 10.
  • Sealing means 8 are provided between the first and second elements at their mutual area of connection.
  • the sealing means 8 are preferably provided as an O-ring sealing member and could be arranged in a groove provided on the outer surface of the piston.
  • the piston 10 is formed with an opening 26 which coincides with the opening 11 of the air outlet or mouth piece 15 of the inhaler.
  • First valve means 18 are provided regulating the air flow through the air outlet and the opening in the piston to the dispersing chamber 20.
  • the valve means are provided as a one way valve arranged to only open when the air flows from the inhaler to the dispersing chamber.
  • the valve could be of any known type and is in the preferred embodiment formed as a thin membrane of which one part is fixed to the wall of the piston and the other end is free moving.
  • the cylinder 6 is formed with a limiting wall member 14 having an outlet opening coinciding with the air outlet of the inhaler.
  • the wall member 14 defines the upper restriction of the dispersing chamber 20 and is provided with holding means 30 for holding the inhaler in a fixed position in relation to the rotation when the maneuvering unit 13 is rotated. These means could be provided as a ratchet mechanism, as teeth rings or have any other construction.
  • Second valve means 16 are provided in said opening for regulating the air flow out from the dispersing chamber upon inhalation of a user.
  • a mouth piece 22 or nose adapter is provided at the end of the cylinder 6.
  • the first and second valves 18 and 16 are preferably of similar construction and must be sensitive and easy to open in order to minimize the inhalation flow resistance and retention of substance within the inhalation device.
  • the valves could preferably be made as thin membranes of plastic or the like.
  • the membranes could be fixed at one end in the opening of the piston 10 and the wall member 14 respectively, as can be seen in the figure.
  • the wall member 14 acts as a valve seat for the valve 18.
  • a further hollow cylinder element 4 is provided.
  • the cylinder is defined by a bottom and wall parts and is opened in its upper region.
  • the bottom of said further cylinder 4 is provided with air inlet openings 5 communicating with the inside of said further cylinder element 4.
  • a mounting element 24 for the inhaler is provided inside said further cylinder and fixed to the bottom of the cylinder.
  • the mounting element 24 comprises a portion 23 adapted to the form of the maneuvering unit 13 of the inhaler in order for it to be fixedly mounted in said mounting means 24.
  • the unit 13 Due to this fixed and rigid mounting of the maneuvering unit 13 of the inhaler 12 in the mounting part 23 the unit 13 is rotated an angle proportional to the rotation of the outer cylinder-formed element 4.
  • the rotation of the outer cylinder-formed element 4 and thereby the maneuvering unit 13 activates the inhaler 12 for inhalation as the maneuvering unit places the dosing unit and thereby a dose in the release position within the inhalation channel.
  • the inner cylinder-formed element 6 is totally interposed into the outer cylinder-formed element 4.
  • the maneuvering unit 13 and the dosing unit of the inhaler is turned and a dose is placed in release position in the inhalation channel.
  • the two cylinder formed elements 4 and 6 are thereafter moved axially in relation to each other whereby the inhaler 12 with the piston 10 is pressed downwards along the inner wall of the inner element 6.
  • a low-pressure or vacuum is created in the dispersing chamber 20 when the elements are moved away from each other.
  • the second valve 16 closes.
  • the valve 18 opens and air is drawn into the inhalation device through the air inlets 5 in the bottom part of the outer element 4.
  • the air passes the inhaler, the dose placed in the inhalation channel is released and dispersed into the dispersing chamber 20.
  • the dispersed substance can now be actively inhaled by the patient, a method which could be used also by small children, elderly people and others with reduced inhalation capacity .
  • the substance can be forced out of the dispersing chamber 20 by pressing the piston 10 and the second element 6 together again after the activation and dispersion of the dose has taken place.
  • the volume in the dispersing chamber will then decrease and an over pressure or positive pressure will be created.
  • the valve 18 will open and air/substance contents of the dispersing chamber 20 will be forced out through the mouth piece 22 of the device. In this manner substance can be forced down into the lungs of the patient.
  • This active pressing out of the substance is especially intended to be used when treating an anesthetized patient but could also be used under other circumstances, e.g. by small children or elderly people refusing to inhale.
  • the inhalation device could also be constructed without the outer cylinder 4.
  • a biasing element 32 is thereby provided between the piston 10, which is mounted on the mouthpiece and/or upper part of the inhaler, and the cylinder 6.
  • the cylinder 6 is provided with stop means 35 provided at the opened end of the cylinder preventing the cylinder from being separated from the piston 10.
  • Further sealing means 34 are provided between the piston 10 and the inhaler 12.
  • the piston 10 in the inactivated position of the device the piston 10 is arranged in relation to the cylinder in such a manner that the dispersing chamber has its largest volume, i.e. the piston and the cylinder are in the retracted position in relation to each other.
  • the piston 10 is then moved within the cylinder 6, i.e. the piston is pushed towards the outlet of the cylinder 6, against the force of the biasing element 32.
  • the volume of the dispersing chamber is decreased.
  • the piston 10 is then released and will due to the force of the biasing element travel instantly towards the bottom of the cylinder thereby creating a negative pressure or vacuum in the dispersing chamber as the volume increases.
  • the dose will be sucked with the air entering into the air inlets of the inhaler to the inhalation channel and further up to the dispersing chamber.
  • the valve 18 will close and the user can inhale through the mouth piece as described above.
  • the biasing element 32 is preferably a spiral spring but any other type of resilient element could be used.
  • the volume of the spacer could be varied due to requirements and needs, and a preferred maximum volume of the dispersing chamber is between 50-250 ml.
  • the different parts of the inhalation device are preferably made of plastics, metallized plastics or metal but other materials are also possible.
  • the present invention is preferably directed to the use of a pharmaceutically active substance in powdered form wherein the powder is dispersed into the dispersing chamber 20 of the inhalation device in a finely divided form wherein the particles are smaller than 10 ⁇ m, preferably smaller than 3 ⁇ m.
  • the means for generating the negative pressure or vacuum are two cylinder-formed elements provided telescopically in relation to each other.
  • the elements have a circular cross-section but any other form such as squared is possible.
  • a further cylinder could be provided in the second element 6.
  • Said further cylinder is arranged to be separately movable in relation to the second element 6, whereby the biasing means are provided in a space between the two cylinders.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
US08/663,266 1994-12-21 1995-12-19 Inhalation device Expired - Lifetime US5983893A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9404439A SE9404439D0 (sv) 1994-12-21 1994-12-21 Inhalation device
SE9404439 1994-12-21
PCT/SE1995/001539 WO1996019253A1 (en) 1994-12-21 1995-12-19 An inhalation device, a method of dispersing a pharmaceutically acitve substance and a method of administering a dose of a pharmaceutically active substance

Publications (1)

Publication Number Publication Date
US5983893A true US5983893A (en) 1999-11-16

Family

ID=20396408

Family Applications (1)

Application Number Title Priority Date Filing Date
US08/663,266 Expired - Lifetime US5983893A (en) 1994-12-21 1995-12-19 Inhalation device

Country Status (25)

Country Link
US (1) US5983893A (no)
EP (1) EP0799067B1 (no)
JP (1) JP3712415B2 (no)
CN (1) CN1171056A (no)
AR (1) AR000522A1 (no)
AT (1) ATE203919T1 (no)
AU (1) AU698815B2 (no)
BR (1) BR9510210A (no)
CA (1) CA2207436A1 (no)
CZ (1) CZ191397A3 (no)
DE (1) DE69522119T2 (no)
EE (1) EE9700132A (no)
FI (1) FI972697A (no)
HU (1) HUT77661A (no)
IL (1) IL116457A0 (no)
IS (2) IS4508A (no)
NO (1) NO972780D0 (no)
NZ (1) NZ298166A (no)
PL (1) PL179323B1 (no)
SE (1) SE9404439D0 (no)
SK (1) SK78297A3 (no)
TR (1) TR199501636A1 (no)
TW (1) TW286285B (no)
WO (1) WO1996019253A1 (no)
ZA (1) ZA9510747B (no)

Cited By (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6237591B1 (en) * 1998-11-02 2001-05-29 Dura Pharmaceuticals, Inc. Turbine dry powder inhaler
WO2001078818A2 (en) * 2000-04-14 2001-10-25 Trudell Medical International Nasal inhaler
US6418925B1 (en) 1999-05-20 2002-07-16 Iep Pharmaceutical Devices Inc. Low spray force, low retention atomization system
US6484715B1 (en) * 1998-07-14 2002-11-26 Ing. Erich Pfeiffer Gmbh Media dispenser
US6606992B1 (en) 1999-06-30 2003-08-19 Nektar Therapeutics Systems and methods for aerosolizing pharmaceutical formulations
US6655379B2 (en) 1998-03-16 2003-12-02 Nektar Therapeutics Aerosolized active agent delivery
US6681767B1 (en) * 1991-07-02 2004-01-27 Nektar Therapeutics Method and device for delivering aerosolized medicaments
US20040065325A1 (en) * 1997-03-14 2004-04-08 Astrazeneca Ab, A Swedish Corporaion Inhalation device
US20050172955A1 (en) * 2004-02-10 2005-08-11 Shivshankar Sundaram Spacer for delivery of medications from an inhaler to children and breathing impaired patients
US20050279349A1 (en) * 1991-07-02 2005-12-22 Patton John S Method and device for delivering aerosolized medicaments
US20060231090A1 (en) * 2005-04-13 2006-10-19 Russell King Inhalation apparatus
US7185651B2 (en) 2002-06-18 2007-03-06 Nektar Therapeutics Flow regulator for aerosol drug delivery and methods
US20070101991A1 (en) * 2005-11-08 2007-05-10 Mederio Ag Optimizing release of dry medicament powder
US20070114480A1 (en) * 2005-11-23 2007-05-24 Burke Joseph M Vorticity generators for use with fluid control systems
US7270127B2 (en) * 2001-01-12 2007-09-18 Becton, Dickinson And Company Medicament respiratory delivery device
US20070215149A1 (en) * 2006-01-31 2007-09-20 Oriel Therapeutics, Inc. Dry powder inhalers having spiral travel paths, unit dose microcartridges with dry powder, related devices and methods
US20080053437A1 (en) * 1999-07-23 2008-03-06 Mannkind Corporation Unit dose capsules and dry powder inhaler
US7464706B2 (en) 1999-07-23 2008-12-16 Mannkind Corporation Unit dose cartridge and dry powder inhaler
US20090241949A1 (en) * 2008-03-27 2009-10-01 Smutney Chad C Dry powder inhalation system
US20100132699A1 (en) * 2007-05-16 2010-06-03 Aradigm Corporation Burst valve for aerosol device
US8408200B2 (en) 1998-10-09 2013-04-02 Novartis Ag Flow resistance modulated aerosolized active agent delivery
US8424518B2 (en) 2008-06-13 2013-04-23 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
US9179691B2 (en) 2007-12-14 2015-11-10 Aerodesigns, Inc. Delivering aerosolizable food products
US9220687B2 (en) 2008-12-29 2015-12-29 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
US9241903B2 (en) 2006-02-22 2016-01-26 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US9283193B2 (en) 2005-09-14 2016-03-15 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9346766B2 (en) 2004-08-20 2016-05-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US9358352B2 (en) 2008-06-13 2016-06-07 Mannkind Corporation Dry powder drug delivery system and methods
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9364436B2 (en) 2011-06-17 2016-06-14 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US9630930B2 (en) 2009-06-12 2017-04-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9700690B2 (en) 2002-03-20 2017-07-11 Mannkind Corporation Inhalation apparatus
US9706944B2 (en) 2009-11-03 2017-07-18 Mannkind Corporation Apparatus and method for simulating inhalation efforts
US9801925B2 (en) 1999-06-29 2017-10-31 Mannkind Corporation Potentiation of glucose elimination
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US9943571B2 (en) 2008-08-11 2018-04-17 Mannkind Corporation Use of ultrarapid acting insulin
US9983108B2 (en) 2009-03-11 2018-05-29 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10421729B2 (en) 2013-03-15 2019-09-24 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US10625034B2 (en) 2011-04-01 2020-04-21 Mannkind Corporation Blister package for pharmaceutical cartridges
WO2020223237A1 (en) 2019-04-29 2020-11-05 Insmed Incorporated Dry powder compositions of treprostinil prodrugs and methods of use thereof
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods
WO2023150747A1 (en) 2022-02-07 2023-08-10 Insmed Incorporated Dry powder compositions of bedaquiline and salts and methods of use thereof

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9513218D0 (en) * 1995-06-29 1995-09-06 Fisons Plc Inhalation device and method
SE9503344D0 (sv) 1995-09-27 1995-09-27 Astra Ab Inhalation device
SE9700935D0 (sv) * 1997-03-14 1997-03-14 Astra Ab Inhalation device
GB9911388D0 (en) 1999-05-18 1999-07-14 Glaxo Group Ltd Dispenser
GB2360219A (en) 2000-03-18 2001-09-19 Astrazeneca Uk Ltd Inhaler
US6554023B2 (en) 2001-06-13 2003-04-29 Baxter International Inc. Vacuum demand flow valve
US6550493B2 (en) 2001-06-13 2003-04-22 Baxter International Inc. Vacuum demand valve
US6863261B2 (en) 2002-03-12 2005-03-08 Baxter International Inc. Valve stop
USD499793S1 (en) 2003-03-17 2004-12-14 Baxter International Inc. Valve
UA94698C2 (uk) * 2004-10-15 2011-06-10 Сіпла Лімітед Система інгалятора і спейсерного пристрою, спейсерний пристрій та його використання
DE102006007495A1 (de) * 2006-02-17 2007-08-23 Siegfried Generics International Ag Dispergiereinheit
CN102553038B (zh) * 2010-12-17 2014-07-02 陈庆堂 药粉吸嘴放置盒
WO2013114374A1 (en) 2012-02-01 2013-08-08 Protalix Ltd. Dnase i polypeptides, polynucleotides encoding same, methods of producing dnase i and uses thereof in therapy
US20170304459A1 (en) 2014-10-10 2017-10-26 Alnylam Pharmaceuticals, Inc. Methods and compositions for inhalation delivery of conjugated oligonucleotide
TWI595902B (zh) 2016-05-10 2017-08-21 明基材料股份有限公司 攜帶型負壓裝置

Citations (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2570774A (en) * 1947-10-21 1951-10-09 Frank P C Davis Insufflator
US2581182A (en) * 1950-03-14 1952-01-01 Abbott Lab Inhaler
US2642063A (en) * 1948-07-31 1953-06-16 Frederick M Turnbull Inhaler
US3658059A (en) * 1968-12-11 1972-04-25 Ritzau Pari Werk Kg Paul Inhaler
US3838686A (en) * 1971-10-14 1974-10-01 G Szekely Aerosol apparatus for inhalation therapy
US4344573A (en) * 1979-06-08 1982-08-17 Hoechst Aktiengesellschaft Spray applicator
US4368850A (en) * 1980-01-17 1983-01-18 George Szekely Dry aerosol generator
US4524769A (en) * 1981-07-08 1985-06-25 Aktiebolaget Draco Dosage inhalator
US4690332A (en) * 1983-11-28 1987-09-01 Nathaniel Hughes Single inlet prepackaged inhaler
US4907583A (en) * 1986-03-07 1990-03-13 Aktiebolaget Draco Device in powder inhalators
US4940051A (en) * 1983-12-28 1990-07-10 Huhtamki Oy Inhalation device
EP0384050A1 (en) * 1986-01-31 1990-08-29 TRUDELL MEDICAL, a partnership consisting of TRUDELL PARTNERSHIP HOLDINGS LIMITED and PACKARD MEDICAL SUPPLY LTD. Pediatric asthmatic medication inhaler
US4955371A (en) * 1989-05-08 1990-09-11 Transtech Scientific, Inc. Disposable inhalation activated, aerosol device for pulmonary medicine
US4972830A (en) * 1985-07-31 1990-11-27 Vortran Medical Technology, Inc. Inhalation device and method
US5033463A (en) * 1989-10-27 1991-07-23 Miat S.P.A. Multi-dose inhaler for medicaments in powder form
US5056511A (en) * 1989-12-14 1991-10-15 Juergen L. Fischer Method and apparatus for compressing, atomizing, and spraying liquid substances
US5062419A (en) * 1991-01-07 1991-11-05 Rider Donald L Nebulizer with valved "T" assembly
US5069204A (en) * 1989-08-23 1991-12-03 Riker Laboratories, Inc. Inhaler
US5239992A (en) * 1991-05-30 1993-08-31 Societe Francaise D'aerosols Et De Bouchage Loose powder inhaler with inhalation-actuated dosing piston
US5341801A (en) * 1991-12-03 1994-08-30 Sandoz Ltd. Inhaler
US5507281A (en) * 1990-08-30 1996-04-16 Boehringer Ingelheim Kg Device for initiating a mechanical switching operation in synchronism with the breathing
US5579760A (en) * 1992-11-06 1996-12-03 Angiomed Ag Process and apparatus for producing an aerosol from a pulverulent substance
US5584288A (en) * 1994-02-03 1996-12-17 Baldwin; Gene R. Multi-stage mouth-to-mouth resuscitator valve
US5623920A (en) * 1992-07-13 1997-04-29 Minnesota Mining And Manufacturing Company Valve assemblies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1217890B (it) * 1988-06-22 1990-03-30 Chiesi Farma Spa Dispositivo per l'inalazione di aerosol dosati
JPH06500717A (ja) * 1990-09-12 1994-01-27 ビスガールト，ハンス 吸入装置

Patent Citations (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2570774A (en) * 1947-10-21 1951-10-09 Frank P C Davis Insufflator
US2642063A (en) * 1948-07-31 1953-06-16 Frederick M Turnbull Inhaler
US2581182A (en) * 1950-03-14 1952-01-01 Abbott Lab Inhaler
US3658059A (en) * 1968-12-11 1972-04-25 Ritzau Pari Werk Kg Paul Inhaler
US3838686A (en) * 1971-10-14 1974-10-01 G Szekely Aerosol apparatus for inhalation therapy
US4344573A (en) * 1979-06-08 1982-08-17 Hoechst Aktiengesellschaft Spray applicator
US4368850A (en) * 1980-01-17 1983-01-18 George Szekely Dry aerosol generator
US4524769A (en) * 1981-07-08 1985-06-25 Aktiebolaget Draco Dosage inhalator
EP0069715B1 (en) * 1981-07-08 1986-11-05 Aktiebolaget Draco Powder inhalator
US4690332A (en) * 1983-11-28 1987-09-01 Nathaniel Hughes Single inlet prepackaged inhaler
US4940051A (en) * 1983-12-28 1990-07-10 Huhtamki Oy Inhalation device
US4972830A (en) * 1985-07-31 1990-11-27 Vortran Medical Technology, Inc. Inhalation device and method
EP0384050A1 (en) * 1986-01-31 1990-08-29 TRUDELL MEDICAL, a partnership consisting of TRUDELL PARTNERSHIP HOLDINGS LIMITED and PACKARD MEDICAL SUPPLY LTD. Pediatric asthmatic medication inhaler
US4907583A (en) * 1986-03-07 1990-03-13 Aktiebolaget Draco Device in powder inhalators
EP0237507B1 (en) * 1986-03-07 1991-12-27 Aktiebolaget Draco Device in powder inhalators
US4955371A (en) * 1989-05-08 1990-09-11 Transtech Scientific, Inc. Disposable inhalation activated, aerosol device for pulmonary medicine
US5069204A (en) * 1989-08-23 1991-12-03 Riker Laboratories, Inc. Inhaler
US5033463A (en) * 1989-10-27 1991-07-23 Miat S.P.A. Multi-dose inhaler for medicaments in powder form
US5056511A (en) * 1989-12-14 1991-10-15 Juergen L. Fischer Method and apparatus for compressing, atomizing, and spraying liquid substances
US5507281A (en) * 1990-08-30 1996-04-16 Boehringer Ingelheim Kg Device for initiating a mechanical switching operation in synchronism with the breathing
US5062419A (en) * 1991-01-07 1991-11-05 Rider Donald L Nebulizer with valved "T" assembly
US5239992A (en) * 1991-05-30 1993-08-31 Societe Francaise D'aerosols Et De Bouchage Loose powder inhaler with inhalation-actuated dosing piston
US5341801A (en) * 1991-12-03 1994-08-30 Sandoz Ltd. Inhaler
US5623920A (en) * 1992-07-13 1997-04-29 Minnesota Mining And Manufacturing Company Valve assemblies
US5579760A (en) * 1992-11-06 1996-12-03 Angiomed Ag Process and apparatus for producing an aerosol from a pulverulent substance
US5584288A (en) * 1994-02-03 1996-12-17 Baldwin; Gene R. Multi-stage mouth-to-mouth resuscitator valve

Cited By (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6681767B1 (en) * 1991-07-02 2004-01-27 Nektar Therapeutics Method and device for delivering aerosolized medicaments
US20050279349A1 (en) * 1991-07-02 2005-12-22 Patton John S Method and device for delivering aerosolized medicaments
US7841340B2 (en) * 1997-03-14 2010-11-30 Astrazeneca Ab Inhaler with powder dislodging member
US7779836B2 (en) 1997-03-14 2010-08-24 Astrazeneca Ab Inhalation device
US20080092886A1 (en) * 1997-03-14 2008-04-24 Astrazeneca Ab, A Sodertalje Sweden Corporation Inhalation device
US20040065325A1 (en) * 1997-03-14 2004-04-08 Astrazeneca Ab, A Swedish Corporaion Inhalation device
US6655379B2 (en) 1998-03-16 2003-12-02 Nektar Therapeutics Aerosolized active agent delivery
US6484715B1 (en) * 1998-07-14 2002-11-26 Ing. Erich Pfeiffer Gmbh Media dispenser
US8408200B2 (en) 1998-10-09 2013-04-02 Novartis Ag Flow resistance modulated aerosolized active agent delivery
US6237591B1 (en) * 1998-11-02 2001-05-29 Dura Pharmaceuticals, Inc. Turbine dry powder inhaler
US6418925B1 (en) 1999-05-20 2002-07-16 Iep Pharmaceutical Devices Inc. Low spray force, low retention atomization system
US9801925B2 (en) 1999-06-29 2017-10-31 Mannkind Corporation Potentiation of glucose elimination
US6606992B1 (en) 1999-06-30 2003-08-19 Nektar Therapeutics Systems and methods for aerosolizing pharmaceutical formulations
US7464706B2 (en) 1999-07-23 2008-12-16 Mannkind Corporation Unit dose cartridge and dry powder inhaler
US8671937B2 (en) 1999-07-23 2014-03-18 Mannkind Corporation Unit dose capsules and dry powder inhaler
US8215300B2 (en) 1999-07-23 2012-07-10 Mannkind Corporation Unit dose cartridge and dry powder inhaler
US9061111B2 (en) 1999-07-23 2015-06-23 Mannkind Corporation Unit dose capsules and dry powder inhaler
US20080053437A1 (en) * 1999-07-23 2008-03-06 Mannkind Corporation Unit dose capsules and dry powder inhaler
US8156936B2 (en) 1999-07-23 2012-04-17 Mannkind Corporation Unit dose capsules and dry powder inhaler
US8950397B2 (en) 1999-07-23 2015-02-10 Mannkind Corporation Unit dose cartridge and dry powder inhaler
WO2001078818A2 (en) * 2000-04-14 2001-10-25 Trudell Medical International Nasal inhaler
WO2001078818A3 (en) * 2000-04-14 2002-04-04 Trudell Medical Int Nasal inhaler
US6644305B2 (en) 2000-04-14 2003-11-11 Trudell Medical International Nasal inhaler
US7270127B2 (en) * 2001-01-12 2007-09-18 Becton, Dickinson And Company Medicament respiratory delivery device
US9700690B2 (en) 2002-03-20 2017-07-11 Mannkind Corporation Inhalation apparatus
US7185651B2 (en) 2002-06-18 2007-03-06 Nektar Therapeutics Flow regulator for aerosol drug delivery and methods
US20050172955A1 (en) * 2004-02-10 2005-08-11 Shivshankar Sundaram Spacer for delivery of medications from an inhaler to children and breathing impaired patients
US7107987B2 (en) 2004-02-10 2006-09-19 Cfd Research Corporation Spacer for delivery of medications from an inhaler to children and breathing impaired patients
US9796688B2 (en) 2004-08-20 2017-10-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US9346766B2 (en) 2004-08-20 2016-05-24 Mannkind Corporation Catalysis of diketopiperazine synthesis
US10130685B2 (en) 2004-08-23 2018-11-20 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US9675674B2 (en) 2004-08-23 2017-06-13 Mannkind Corporation Diketopiperazine salts for drug delivery and related methods
US7493898B2 (en) * 2005-04-13 2009-02-24 Healthline Medical, Inc. Inhalation apparatus
US20060231090A1 (en) * 2005-04-13 2006-10-19 Russell King Inhalation apparatus
US9283193B2 (en) 2005-09-14 2016-03-15 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US9717689B2 (en) 2005-09-14 2017-08-01 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US10143655B2 (en) 2005-09-14 2018-12-04 Mannkind Corporation Method of drug formulation
US9446001B2 (en) 2005-09-14 2016-09-20 Mannkind Corporation Increasing drug affinity for crystalline microparticle surfaces
US20070101991A1 (en) * 2005-11-08 2007-05-10 Mederio Ag Optimizing release of dry medicament powder
US20070114480A1 (en) * 2005-11-23 2007-05-24 Burke Joseph M Vorticity generators for use with fluid control systems
US20070215149A1 (en) * 2006-01-31 2007-09-20 Oriel Therapeutics, Inc. Dry powder inhalers having spiral travel paths, unit dose microcartridges with dry powder, related devices and methods
US7987845B2 (en) 2006-01-31 2011-08-02 Oriel Therapeutics, Inc. Dry powder inhalers having spiral travel paths, unit dose microcartridges with dry powder, related devices and methods
US8375941B2 (en) 2006-01-31 2013-02-19 Oriel Therapeutics, Inc. Methods of operating dry powder inhalers having spiral travel paths with microcartridges of dry powder
US9241903B2 (en) 2006-02-22 2016-01-26 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US10130581B2 (en) 2006-02-22 2018-11-20 Mannkind Corporation Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent
US20100132699A1 (en) * 2007-05-16 2010-06-03 Aradigm Corporation Burst valve for aerosol device
US9179691B2 (en) 2007-12-14 2015-11-10 Aerodesigns, Inc. Delivering aerosolizable food products
US20090241949A1 (en) * 2008-03-27 2009-10-01 Smutney Chad C Dry powder inhalation system
US8424518B2 (en) 2008-06-13 2013-04-23 Mannkind Corporation Dry powder inhaler and system for drug delivery
US10342938B2 (en) 2008-06-13 2019-07-09 Mannkind Corporation Dry powder drug delivery system
US9192675B2 (en) 2008-06-13 2015-11-24 Mankind Corporation Dry powder inhaler and system for drug delivery
US9393372B2 (en) 2008-06-13 2016-07-19 Mannkind Corporation Dry powder drug delivery system
US9446133B2 (en) 2008-06-13 2016-09-20 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
US9511198B2 (en) 2008-06-13 2016-12-06 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8636001B2 (en) 2008-06-13 2014-01-28 Mannkind Corporation Dry powder inhaler and system for drug delivery
US10201672B2 (en) 2008-06-13 2019-02-12 Mannkind Corporation Dry powder inhaler and system for drug delivery
US10751488B2 (en) 2008-06-13 2020-08-25 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9662461B2 (en) 2008-06-13 2017-05-30 Mannkind Corporation Dry powder drug delivery system and methods
US8499757B2 (en) 2008-06-13 2013-08-06 Mannkind Corporation Dry powder inhaler and system for drug delivery
US8912193B2 (en) 2008-06-13 2014-12-16 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9339615B2 (en) 2008-06-13 2016-05-17 Mannkind Corporation Dry powder inhaler and system for drug delivery
US9358352B2 (en) 2008-06-13 2016-06-07 Mannkind Corporation Dry powder drug delivery system and methods
US9364619B2 (en) 2008-06-20 2016-06-14 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US10675421B2 (en) 2008-06-20 2020-06-09 Mannkind Corporation Interactive apparatus and method for real-time profiling of inhalation efforts
US9943571B2 (en) 2008-08-11 2018-04-17 Mannkind Corporation Use of ultrarapid acting insulin
US9220687B2 (en) 2008-12-29 2015-12-29 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US10172850B2 (en) 2008-12-29 2019-01-08 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9655850B2 (en) 2008-12-29 2017-05-23 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
US9983108B2 (en) 2009-03-11 2018-05-29 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
US9630930B2 (en) 2009-06-12 2017-04-25 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
US9706944B2 (en) 2009-11-03 2017-07-18 Mannkind Corporation Apparatus and method for simulating inhalation efforts
US10625034B2 (en) 2011-04-01 2020-04-21 Mannkind Corporation Blister package for pharmaceutical cartridges
US9364436B2 (en) 2011-06-17 2016-06-14 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US10130709B2 (en) 2011-06-17 2018-11-20 Mannkind Corporation High capacity diketopiperazine microparticles and methods
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
US10258664B2 (en) 2011-10-24 2019-04-16 Mannkind Corporation Methods and compositions for treating pain
US9610351B2 (en) 2011-10-24 2017-04-04 Mannkind Corporation Methods and compositions for treating pain
US9802012B2 (en) 2012-07-12 2017-10-31 Mannkind Corporation Dry powder drug delivery system and methods
US10159644B2 (en) 2012-10-26 2018-12-25 Mannkind Corporation Inhalable vaccine compositions and methods
US10421729B2 (en) 2013-03-15 2019-09-24 Mannkind Corporation Microcrystalline diketopiperazine compositions and methods
US9925144B2 (en) 2013-07-18 2018-03-27 Mannkind Corporation Heat-stable dry powder pharmaceutical compositions and methods
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods
US10307464B2 (en) 2014-03-28 2019-06-04 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
WO2020223237A1 (en) 2019-04-29 2020-11-05 Insmed Incorporated Dry powder compositions of treprostinil prodrugs and methods of use thereof
WO2023150747A1 (en) 2022-02-07 2023-08-10 Insmed Incorporated Dry powder compositions of bedaquiline and salts and methods of use thereof

Also Published As

Publication number Publication date
MX9704489A (es) 1997-10-31
WO1996019253A1 (en) 1996-06-27
CN1171056A (zh) 1998-01-21
JPH10510742A (ja) 1998-10-20
EP0799067A1 (en) 1997-10-08
CZ191397A3 (en) 1997-10-15
AU4359096A (en) 1996-07-10
TW286285B (no) 1996-09-21
NO972780L (no) 1997-06-16
IS4509A (is) 1997-06-18
CA2207436A1 (en) 1996-06-27
ZA9510747B (en) 1996-06-28
SE9404439D0 (sv) 1994-12-21
DE69522119T2 (de) 2002-06-06
DE69522119D1 (de) 2001-09-13
NZ298166A (en) 1999-01-28
NO972780D0 (no) 1997-06-16
EE9700132A (et) 1997-12-15
JP3712415B2 (ja) 2005-11-02
PL179323B1 (pl) 2000-08-31
FI972697A0 (fi) 1997-06-23
IS4508A (is) 1997-06-16
AR000522A1 (es) 1997-07-10
FI972697A (fi) 1997-06-23
IL116457A0 (en) 1996-03-31
TR199501636A1 (tr) 1997-03-21
HUT77661A (hu) 1998-07-28
ATE203919T1 (de) 2001-08-15
PL320860A1 (en) 1997-11-10
AU698815B2 (en) 1998-11-05
EP0799067B1 (en) 2001-08-08
BR9510210A (pt) 1997-11-04
SK78297A3 (en) 1998-02-04

Similar Documents

Publication Publication Date Title
US5983893A (en) Inhalation device
US6286506B1 (en) Inhalation device
CA2225750C (en) Inhalation device and method
JP5069653B2 (ja) 呼吸作動式薬剤投与装置
US5161524A (en) Dosage inhalator with air flow velocity regulating means
US6892728B2 (en) Inhalation device
EP1191966B1 (en) Inhaler
JP2535297B2 (ja) 医薬分与装置
EP0714314B1 (en) Inhalator with breath flow regulation
JP2004508900A (ja) 呼吸−作動
WO1997031668A1 (en) Power spacer
MXPA97004489A (en) Inhalation device, method for dispersing a pharmaceutically active substance and method for administering a dose of a pharmaceutically acting substance
KR970009724B1 (ko) 약제 투여장치
MXPA98000223A (en) Device and method of inhalac

Legal Events

Date Code Title Description
AS Assignment

Owner name: ASTRA AKTIEBOLAG, SWEDEN

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:WETTERLIN KJELL;REEL/FRAME:008640/0418

Effective date: 19960111

STCF Information on status: patent grant

Free format text: PATENTED CASE

FPAY Fee payment

Year of fee payment: 4

REMI Maintenance fee reminder mailed
FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12